Tandem Mobi Becomes Only Insulin Pump Offering Both Tubed and Tubeless Wear Options
FDA clears Tandem Diabetes Care's Tandem Mobi as the first tubeless automated insulin delivery system with seven-day wear launching in 2027.
Last updated: 2026-11-16 03:00:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Tandem Diabetes Care, Inc. (TNDM) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $20.07, with a market capitalization of $1.40B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $12.26 to $29.65. This page covers its latest market performance, valuation, price trends and company information.
$1.40B | |
$19.00 | |
$20.50 | |
$17.34 | |
$17.51 | |
4.10M | |
2.23M | |
-- | |
$29.65 | |
$12.26 | |
-- | |
-- |
Tandem Diabetes Care, Inc. (TNDM) last closed at $20.07 as of 2026-11-14 00:40:00, up 14.56% ($2.55) from the previous close of $17.51.
During the latest regular trading session, TNDM traded between $17.34 and $20.50, with a volume of 4.10M shares. The closing price was near the upper end and near the middle of its 52-week range.
Over the past seven days, Tandem Diabetes Care, Inc. (TNDM) moved from $17.99 to $20.07, representing a gain of 11.53% ($2.08).
The stock traded between $15.45 and $20.50 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 3.35 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 44.9%
TNDM is currently trading at $20.07, placing it 44.9% of the way from its 52-week low of $12.26 to its 52-week high of $29.65. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 2,500 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to Tandem Diabetes Care, Inc. and TNDM stock.
FDA clears Tandem Diabetes Care's Tandem Mobi as the first tubeless automated insulin delivery system with seven-day wear launching in 2027.
Eligible investors can buy real shares of Tandem Diabetes Care, Inc. (TNDM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to TNDM, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between TNDM shares and USD.
TNDM Shares to USD
1.00 TNDM shares = 20.065 USD
Calculations are estimates based on the latest available price and are for reference only.